Home › Funds › KVP Capital Advisors, LP › SVRA
KVP Capital Advisors, LP position in SVRA
SAVARA INC · Health Care
KVP Capital Advisors, LP reported holding 605,280 shares of SVRA (SAVARA INC) in its Q3 2026 13F filing — a position valued at US$3.1M, representing 2.55% of its reported portfolio and ranking #14 among its reported holdings. KVP Capital Advisors, LP has disclosed SVRA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How KVP Capital Advisors, LP's SVRA position evolved
KVP Capital Advisors, LP first disclosed a stake in SVRA in Q4 2025 at 605,280 shares (US$3.6M). The position peaked in Q2 2026 at 605,280 shares, worth US$3.7M. Across 4 filings, KVP Capital Advisors, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 605,280 shares valued at US$3.1M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 605.28K | $3.65M | New |
| Q1 2026 | 605.28K | $3.30M | Hold |
| Q2 2026 | 605.28K | $3.73M | Hold |
| Q3 2026 | 605.28K | $3.12M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SVRA and 13F data
SVRA (SAVARA INC) is a Health Care company. 39 other funds we track also report a position in SVRA — the largest reported positions include NEA Management Company, LLC (US$150.7M), Venrock Adviser, LLC (US$90.8M), Bain Capital Life Sciences Investors, LLC (US$90.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SVRA
- NEA Management Company, LLC 24.47M sh · $150.74M · Q2 2026
- Venrock Adviser, LLC 14.75M sh · $90.84M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 17.60M sh · $90.82M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 13.57M sh · $83.59M · Q2 2026
- TCG Crossover Management, LLC 12.36M sh · $63.79M · Q3 2026
- Frazier Life Sciences Management, L.P. 9.72M sh · $59.88M · Q2 2026
- Nantahala Capital Management, LLC 7.14M sh · $36.83M · Q3 2026
- Spruce Street Capital LP 5.38M sh · $27.77M · Q3 2026
- Vestal Point Capital, LP 2.72M sh · $16.76M · Q2 2026
- Rosalind Advisors, Inc. 3.18M sh · $16.40M · Q3 2026
- Affinity Asset Advisors, LLC 2.51M sh · $12.96M · Q3 2026
- NAN FUNG TRINITY (HK) Ltd 1.84M sh · $9.51M · Q3 2026
More on KVP Capital Advisors, LP
FAQ
How long has KVP Capital Advisors, LP held SVRA?
KVP Capital Advisors, LP has disclosed SVRA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is KVP Capital Advisors, LP's current position in SVRA?
As of Q3 2026, KVP Capital Advisors, LP holds 605.28K shares of SVRA (SAVARA INC), valued at $3.12M, representing 2.55% of its reported portfolio and ranking #14.
Has KVP Capital Advisors, LP been buying or selling SVRA?
In the latest 13F filing (Q3 2026), KVP Capital Advisors, LP held unchanged its position in SVRA. The position peaked in Q2 2026 at 605.28K shares.
Which other funds hold SVRA?
Other major institutional holders of SVRA include NEA Management Company, LLC, Venrock Adviser, LLC, Bain Capital Life Sciences Investors, LLC, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.